A Study of HMPL-523 in Relapsed or Refractory Hematologic Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chen Yu, MD
Hutchison Medi Pharma
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Canberra Hospital
Canberra, Australian Capital Territory, Australia
- Border Medical Oncology Research Unit
Albury, New South Wales, Australia
- Liverpool Hospital
Liverpool, New South Wales, Australia
- Townsville Hospital
Townsville, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Ballarat Regional Integrated Cancer Centre
Ballarat, Victoria, Australia
- St Vincent'S Hospital
Fitzroy, Victoria, Australia
- Peninsula & South Eastern Haematology and Oncology Group
Frankston, Victoria, Australia
- Barwon Health
Geelong, Victoria, Australia
- Austin Hospital
Heidelberg, Victoria, Australia
- Cabrini Health
Melbourne, Victoria, Australia
- Royal Perth Hospital
Perth, Western Australia, Australia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2015
- Primary completion
- 31 Dec 2020
- Completion
- 31 Mar 2021
- Last update posted
- 11 Sept 2020
- Registered enrollment
- 78
- Registry id
- NCT02503033
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.